MedTrace Logo

Prediction of Response to Neoadjuvant Therapy in Rectal Cancer

NCT02439086 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether 18F-FDG-PET-CT and texture analysis of MRI performed 9 weeks after Neoadjuvant Chemo-radiotherapy in patients with locally advanced rectal cancer has the ability to identify patients with Complete Response.

Conditions

  • Rectal Neoplasms

Interventions

DEVICE

PET-CT Scan

patients will have 2 PET CT scans: one before radiotherapy, and one 9 weeks after.

Sponsors & Collaborators

  • Anglia Ruskin University

    collaborator OTHER

  • Colchester General Hospital

    lead OTHER

Principal Investigators

  • Tan Arulampalam, MD · ICENI Centre director

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02439086 on ClinicalTrials.gov